Global Viral Molecular Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Hepatitis B Virus (HBV)
1.2.3 Hepatitis C Virus (HCV)
1.2.4 Human Immunodeficiency Virus (HIV)
1.2.5 Human Papillomavirus (HPV)
1.3 Market by Application
1.3.1 Global Viral Molecular Diagnostics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Academics Institutions
1.3.4 Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Viral Molecular Diagnostics Market Size (2017-2028)
2.2 Viral Molecular Diagnostics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Viral Molecular Diagnostics Market Size by Region (2017-2022)
2.4 Global Viral Molecular Diagnostics Market Size Forecast by Region (2023-2028)
2.5 Global Top Viral Molecular Diagnostics Countries Ranking by Market Size
3 Viral Molecular Diagnostics Competitive by Company
3.1 Global Viral Molecular Diagnostics Revenue by Players
3.1.1 Global Viral Molecular Diagnostics Revenue by Players (2017-2022)
3.1.2 Global Viral Molecular Diagnostics Market Share by Players (2017-2022)
3.2 Global Viral Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Viral Molecular Diagnostics Revenue
3.4 Global Viral Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Viral Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Molecular Diagnostics Revenue in 2021
3.5 Global Viral Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Viral Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Viral Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Viral Molecular Diagnostics Breakdown Data by Type
4.1 Global Viral Molecular Diagnostics Historic Revenue by Type (2017-2022)
4.2 Global Viral Molecular Diagnostics Forecasted Revenue by Type (2023-2028)
5 Global Viral Molecular Diagnostics Breakdown Data by Application
5.1 Global Viral Molecular Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Viral Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Viral Molecular Diagnostics Revenue by Company (2020-2022)
6.2 North America Viral Molecular Diagnostics Revenue by Type (2017-2028)
6.3 North America Viral Molecular Diagnostics Revenue by Application (2017-2028)
6.4 North America Viral Molecular Diagnostics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Viral Molecular Diagnostics Revenue by Company (2020-2022)
7.2 Europe Viral Molecular Diagnostics Revenue by Type (2017-2028)
7.3 Europe Viral Molecular Diagnostics Revenue by Application (2017-2028)
7.4 Europe Viral Molecular Diagnostics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Viral Molecular Diagnostics Revenue by Company (2020-2022)
8.2 Asia Pacific Viral Molecular Diagnostics Revenue by Type (2017-2028)
8.3 Asia Pacific Viral Molecular Diagnostics Revenue by Application (2017-2028)
8.4 Asia Pacific Viral Molecular Diagnostics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Viral Molecular Diagnostics Revenue by Company (2020-2022)
9.2 Latin America Viral Molecular Diagnostics Revenue by Type (2017-2028)
9.3 Latin America Viral Molecular Diagnostics Revenue by Application (2017-2028)
9.4 Latin America Viral Molecular Diagnostics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Viral Molecular Diagnostics Revenue by Company (2020-2022)
10.2 Middle East and Africa Viral Molecular Diagnostics Revenue by Type (2017-2028)
10.3 Middle East and Africa Viral Molecular Diagnostics Revenue by Application (2017-2028)
10.4 Middle East and Africa Viral Molecular Diagnostics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Abbott Laboraories
11.1.1 Abbott Laboraories Company Details
11.1.2 Abbott Laboraories Business Overview
11.1.3 Abbott Laboraories Viral Molecular Diagnostics Products and Services
11.1.4 Abbott Laboraories Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.1.5 Abbott Laboraories Viral Molecular Diagnostics SWOT Analysis
11.1.6 Abbott Laboraories Recent Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Products and Services
11.2.4 Bio-Rad Laboratories Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.2.5 Bio-Rad Laboratories Viral Molecular Diagnostics SWOT Analysis
11.2.6 Bio-Rad Laboratories Recent Developments
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Details
11.3.2 Becton, Dickinson Business Overview
11.3.3 Becton, Dickinson Viral Molecular Diagnostics Products and Services
11.3.4 Becton, Dickinson Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.3.5 Becton, Dickinson Viral Molecular Diagnostics SWOT Analysis
11.3.6 Becton, Dickinson Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Viral Molecular Diagnostics Products and Services
11.4.4 Roche Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.4.5 Roche Viral Molecular Diagnostics SWOT Analysis
11.4.6 Roche Recent Developments
11.5 Gen-Probe
11.5.1 Gen-Probe Company Details
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe Viral Molecular Diagnostics Products and Services
11.5.4 Gen-Probe Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.5.5 Gen-Probe Viral Molecular Diagnostics SWOT Analysis
11.5.6 Gen-Probe Recent Developments
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Viral Molecular Diagnostics Products and Services
11.6.4 Qiagen Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.6.5 Qiagen Viral Molecular Diagnostics SWOT Analysis
11.6.6 Qiagen Recent Developments
11.7 Olympus
11.7.1 Olympus Company Details
11.7.2 Olympus Business Overview
11.7.3 Olympus Viral Molecular Diagnostics Products and Services
11.7.4 Olympus Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.7.5 Olympus Viral Molecular Diagnostics SWOT Analysis
11.7.6 Olympus Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Products and Services
11.8.4 Thermo Fisher Scientific Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022)
11.8.5 Thermo Fisher Scientific Viral Molecular Diagnostics SWOT Analysis
11.8.6 Thermo Fisher Scientific Recent Developments
12 Viral Molecular Diagnostics Market Dynamics
12.1 Viral Molecular Diagnostics Market Trends
12.2 Viral Molecular Diagnostics Market Drivers
12.3 Viral Molecular Diagnostics Market Challenges
12.4 Viral Molecular Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Viral Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Hepatitis B Virus (HBV)
Table 3. Key Players of Hepatitis C Virus (HCV)
Table 4. Key Players of Human Immunodeficiency Virus (HIV)
Table 5. Key Players of Human Papillomavirus (HPV)
Table 6. Global Viral Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Viral Molecular Diagnostics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Viral Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Viral Molecular Diagnostics Revenue Market Share by Region (2017-2022)
Table 10. Global Viral Molecular Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Viral Molecular Diagnostics Market Share by Players (2017-2022)
Table 12. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Molecular Diagnostics as of 2021)
Table 13. Ranking of Global Top Viral Molecular Diagnostics Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Viral Molecular Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Viral Molecular Diagnostics Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Viral Molecular Diagnostics Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Viral Molecular Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Viral Molecular Diagnostics Revenue Market Share by Type (2017-2022)
Table 21. Global Viral Molecular Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Viral Molecular Diagnostics Revenue Market Share by Type (2023-2028)
Table 23. Global Viral Molecular Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Viral Molecular Diagnostics Revenue Market Share by Application (2017-2022)
Table 25. Global Viral Molecular Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Viral Molecular Diagnostics Revenue Market Share by Application (2023-2028)
Table 27. North America Viral Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Viral Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Viral Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Viral Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Viral Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Viral Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Viral Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Viral Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Viral Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Viral Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Viral Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Viral Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Viral Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Viral Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Viral Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Viral Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Viral Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Viral Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Viral Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Viral Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Viral Molecular Diagnostics Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Viral Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Viral Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Viral Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Viral Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Viral Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Viral Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Viral Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Viral Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Viral Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Viral Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Viral Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Viral Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Viral Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Viral Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 62. Abbott Laboraories Company Details
Table 63. Abbott Laboraories Business Overview
Table 64. Abbott Laboraories Viral Molecular Diagnostics Product and Services
Table 65. Abbott Laboraories Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 66. Abbott Laboraories Viral Molecular Diagnostics SWOT Analysis
Table 67. Abbott Laboraories Recent Developments
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories Viral Molecular Diagnostics Product and Services
Table 71. Bio-Rad Laboratories Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 72. Bio-Rad Laboratories Viral Molecular Diagnostics SWOT Analysis
Table 73. Bio-Rad Laboratories Recent Developments
Table 74. Becton, Dickinson Company Details
Table 75. Becton, Dickinson Business Overview
Table 76. Becton, Dickinson Viral Molecular Diagnostics Product and Services
Table 77. Becton, Dickinson Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 78. Becton, Dickinson Viral Molecular Diagnostics SWOT Analysis
Table 79. Becton, Dickinson Recent Developments
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Viral Molecular Diagnostics Product and Services
Table 83. Roche Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 84. Roche Viral Molecular Diagnostics SWOT Analysis
Table 85. Roche Recent Developments
Table 86. Gen-Probe Company Details
Table 87. Gen-Probe Business Overview
Table 88. Gen-Probe Viral Molecular Diagnostics Product and Services
Table 89. Gen-Probe Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 90. Gen-Probe Viral Molecular Diagnostics SWOT Analysis
Table 91. Gen-Probe Recent Developments
Table 92. Qiagen Company Details
Table 93. Qiagen Business Overview
Table 94. Qiagen Viral Molecular Diagnostics Product and Services
Table 95. Qiagen Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 96. Qiagen Viral Molecular Diagnostics SWOT Analysis
Table 97. Qiagen Recent Developments
Table 98. Olympus Company Details
Table 99. Olympus Business Overview
Table 100. Olympus Viral Molecular Diagnostics Product and Services
Table 101. Olympus Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 102. Olympus Viral Molecular Diagnostics SWOT Analysis
Table 103. Olympus Recent Developments
Table 104. Thermo Fisher Scientific Company Details
Table 105. Thermo Fisher Scientific Business Overview
Table 106. Thermo Fisher Scientific Viral Molecular Diagnostics Product and Services
Table 107. Thermo Fisher Scientific Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 108. Thermo Fisher Scientific Viral Molecular Diagnostics SWOT Analysis
Table 109. Thermo Fisher Scientific Recent Developments
Table 110. Viral Molecular Diagnostics Market Trends
Table 111. Viral Molecular Diagnostics Market Drivers
Table 112. Viral Molecular Diagnostics Market Challenges
Table 113. Viral Molecular Diagnostics Market Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Viral Molecular Diagnostics Sales Market Share by Type: 2021 VS 2028
Figure 2. Hepatitis B Virus (HBV) Features
Figure 3. Hepatitis C Virus (HCV) Features
Figure 4. Human Immunodeficiency Virus (HIV) Features
Figure 5. Human Papillomavirus (HPV) Features
Figure 6. Global Viral Molecular Diagnostics Sales Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Academics Institutions Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Others Case Studies
Figure 11. Viral Molecular Diagnostics Report Years Considered
Figure 12. Global Viral Molecular Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Viral Molecular Diagnostics Market Size 2017-2028 (US$ Million)
Figure 14. Global Viral Molecular Diagnostics Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Viral Molecular Diagnostics Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Viral Molecular Diagnostics Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Viral Molecular Diagnostics Market Share by Players in 2021
Figure 18. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Molecular Diagnostics as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Viral Molecular Diagnostics Revenue in 2021
Figure 20. North America Viral Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 21. North America Viral Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 22. North America Viral Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 23. North America Viral Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 24. U.S. Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Viral Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 27. Europe Viral Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 28. Europe Viral Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 29. Europe Viral Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 30. Germany Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 31. France Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Viral Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Viral Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Viral Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Viral Molecular Diagnostics Revenue Share by Region (2017-2028)
Figure 39. China Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 42. India Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 44. Taiwan Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 48. Philippines Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 49. Vietnam Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 50. Latin America Viral Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 51. Latin America Viral Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 52. Latin America Viral Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 53. Latin America Viral Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 54. Mexico Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 55. Brazil Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 56. Argentina Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 57. Middle East and Africa Viral Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 58. Middle East and Africa Viral Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Viral Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Viral Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 61. Turkey Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 63. UAE Viral Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 64. Abbott Laboraories Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 66. Becton, Dickinson Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 67. Roche Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 68. Gen-Probe Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 69. Qiagen Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 70. Olympus Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Viral Molecular Diagnostics Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed